138 related articles for article (PubMed ID: 9788200)
21. The Lambert-Eaton myasthenic syndrome.
Sanders DB
Adv Neurol; 2002; 88():189-201. PubMed ID: 11908225
[No Abstract] [Full Text] [Related]
22. Interaction of synaptotagmin with voltage gated calcium channels: a role in Lambert-Eaton myasthenic syndrome?
David P; Martin-Moutot N; Leveque C; el Far O; Takahashi M; Seagar MJ
Neuromuscul Disord; 1993; 3(5-6):451-4. PubMed ID: 8186692
[TBL] [Abstract][Full Text] [Related]
23. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?
Fletcher CF; Lennon VA
Ann Neurol; 2003 Jan; 53(1):5-7. PubMed ID: 12509841
[No Abstract] [Full Text] [Related]
24. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen.
Rosenfeld MR; Wong E; Dalmau J; Manley G; Posner JB; Sher E; Furneaux HM
Ann Neurol; 1993 Jan; 33(1):113-20. PubMed ID: 8494331
[TBL] [Abstract][Full Text] [Related]
25. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
[No Abstract] [Full Text] [Related]
26. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
28. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M
Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869
[TBL] [Abstract][Full Text] [Related]
29. Sera from patients with Lambert-Eaton myasthenic syndrome recognize the beta-subunit of Ca2+ channel complexes.
Rosenfeld MR; Wong E; Dalmau J; Manley G; Egan D; Posner JB; Sher E; Furneaux HM
Ann N Y Acad Sci; 1993 Jun; 681():408-11. PubMed ID: 8395157
[No Abstract] [Full Text] [Related]
30. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
[No Abstract] [Full Text] [Related]
31. [Biochemical approaches to neuromuscular junction disorders].
Takamori M
Rinsho Shinkeigaku; 1996 Dec; 36(12):1363-4. PubMed ID: 9128412
[TBL] [Abstract][Full Text] [Related]
32. [Lambert-Eaton myasthenic syndrome(LEMS)].
Inuzuka T
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):377-9. PubMed ID: 11031974
[No Abstract] [Full Text] [Related]
33. Lambert-Eaton myasthenic syndrome. Antigenicity of recombinant human P/Q-type calcium channel alpha 1 subunit putative ion pore region (domain IV, S5-S6).
Black JL; Griesmann GE; Erickson J; Kryzer TJ; Lamke GT; Lennon VA
Ann N Y Acad Sci; 1998 May; 841():691-5. PubMed ID: 9668316
[No Abstract] [Full Text] [Related]
34. A Lambert-Eaton myasthenic syndrome antigen associated with presynaptic calcium channels.
Seagar MJ; Martin-Moutot N; Leveque C; el Far O; David P; Marqueze B; Lang B; Newsom-Davis J; Hoshino T; Takahashi M
Biochem Soc Trans; 1993 May; 21(2):423-8. PubMed ID: 8395427
[No Abstract] [Full Text] [Related]
35. Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.
Leys K; Lang B; Vincent A; Newsom-Davis J
Lancet; 1989 Nov; 2(8671):1107. PubMed ID: 2572837
[No Abstract] [Full Text] [Related]
36. Lambert-Eaton myasthenic syndrome in childhood.
Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
[TBL] [Abstract][Full Text] [Related]
37. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
38. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
Sher E; Carbone E; Clementi F
Ann N Y Acad Sci; 1993 Jun; 681():373-81. PubMed ID: 8395151
[No Abstract] [Full Text] [Related]
39. Differential effect of Lambert-Eaton myasthenic syndrome immunoglobulin on cloned neuronal voltage-gated calcium channels.
Pinto A; Moss F; Lang B; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():687-90. PubMed ID: 9668315
[No Abstract] [Full Text] [Related]
40. Myasthenia gravis and myasthenic syndrome.
Antozzi C
Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
